Search results for: 'missile clinical iot'

This research service provides a snapshot of the missile systems market in the Asia-Pacific (APAC). The study covers select APAC countries, focusing on Australia, India, Japan, and South Korea and briefly analyzing Guam (a US territory), Indonesia, Malaysia, the Philippines, Vietnam, and Taiwan. The research service examines the competitive landsc...

In this study, Frost & Sullivan overviews the US Department of Defense’s missile defense spending between FY2023 and FY2029. The study outlines the department’s funding distribution among military branches, budget activity titles, and a forecast with future spending estimates. It also highlights the trends, challenges, drivers, and restraints the D...

The Russo-Ukrainian war and the Israeli military campaign against the Hamas terrorist group in Gaza both underscore the importance of maneuvering armored vehicles to maximize military objectives on the battlefield. As a result of the impressive operational performance of MBTs, there is increasing demand for affordable, user-friendly, and lethal ant...

03 Jul 2024  |  Europe  |  Market Research

Growth Opportunities in European Missile Defense, 2024 2029

The Regional Conflict Landscape Ensures Future Growth Potential

Infographics

×

In this research service, Frost & Sullivan overviews the European missile defense market, highlighting trends, challenges, drivers, restraints, and growth opportunities. The study provides an outlook on regional conflicts and recent developments in the field and contains an analysis of the market s competitive environment. The demand for militar...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of clinical trials that make decentralization necess...

With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare and precision medicine, as the clinical diagnostics industry continues its transition from a centralized to a decentralized testing model. Globally, 2024 is set to be a profitable year for the industry, which will ...

The impact of Covid-19 continues to reverberate in the Internet of Things (IoT). In addition, the fears of a global recession will have an impact on the market. While this impact is likely to be felt more in the EMEA region, other regions will be impacted by the global recession and inflationery pressures. This Reforecast of the IoT space shows tha...